NBA star Kristaps Porzingis and Jordi Cruyff invest in Israeli start-up Zone7 – Israel News


Share on Facebook
Share on Twitter


Eyal Eliakim (left), technical director and co-founder of Zone7, with CEO and co-founder, Tal Brown.
(photo credit: ZONE7)


Dear reader,

As you can imagine, more people are reading the Jerusalem Post than ever before.
Nevertheless, traditional economic models are no longer sustainable and quality publications,
like ours, are forced to look for new ways to continue. Unlike many other media outlets,
we have not set up paywall. We want to keep our journalism open
and accessible and be able to continue to provide you with news
and analyzes of the front lines of Israel, the Middle East and the Jewish world.

As one of our faithful readers, we ask you to be our partner.

For $ 5 per month, you will have access to the following:

  • A user experience almost completely devoid of ads
  • Access to our Premium section
  • Content of the award-winning Jerusalem Report and our monthly magazine to learn Hebrew – Ivrit
  • A brand new electronic paper presenting the daily newspaper as it appears in Israel
  • Help us grow and continue to tell the story of Israel to the world.

    Thank you,

    Ronit Hasin-Hochman, CEO, Jerusalem Post Group
    Yaakov Katz, Editor-in-Chief


    Show me later

    The Israeli-American sports injury prevention start-up, Zone7, has raised $ 2.5 million in seed money, a group of investors led by Resolute Ventures announced Tuesday, with the participation of Kristaps Porzingis of the Dallas Mavericks and former Dutch football star Jordi Cruyff.

    UpWest, Amicus Capital, Dave Pell and PLG Ventures also participated in the company's financing cycle based in Tel Aviv and Palo Alto, California.

    Co-founded by Tal Brown and Eyal Eliakim, former members of the IDF Intelligence Unit, 8200, Zone7 connects to athlete medical and performance data, and uses a form-based pattern recognition software. Artificial intelligence to identify the risk of injury and simulate the evolution of the training, the impact on the job.

    Simple, actionable recommendations to reduce risk are then sent to personal mobile devices so that coaches, coaches and doctors can make real-time decisions in the field.

    The platform, which has already logged more than five million hours of athletic performance, is currently used by teams in Major League Baseball, La Liga, Champions League, Major League Soccer, Sports Teams and the Olympic teams.

    "Getting hurt is one of the worst experiences for an athlete," said Porzingis, who joined Dallas Mavericks last month after being handed a torn ACL while she was playing for the New York Knicks.

    "The technology behind Zone7 is extremely impressive and has the potential to change the sport landscape forever."

    His fellow investor Jordi Cruyff, formerly of Barcelona and Manchester United, spent six years in Israel as of April 2012 as sports director of Maccabi Tel Aviv and, as of June 2017, as director of club.

    According to the company, Zone7 has gained ground in the world of professional sports after football teams using this technology have reported a 75% reduction in the injury rate. The company currently runs pilot programs with several major league baseball franchises after presenting its technology at the MLB Winter Meetings in Las Vegas.

    "Injuries in professional sports cost billions of dollars a year, but in the era of big data, this is no longer the case," said Tal Brown, co-founder and CEO of Zone7.

    "Professional sports franchises contain huge amounts of untapped health and performance data that, once unlocked by AI, can become one of the team's most valuable assets. By better understanding each athlete's break points and putting in place personalized response plans to prevent injuries before they occur, teams are no longer forced to accept injuries as a foregone conclusion. "

    Join Jerusalem Post Premium Plus now for just $ 5 and enhance your experience with an ad-free website and exclusive content. Click here >>

    Share on Facebook
    Share on Twitter